Get started
Author

Gerardo Ferrara

Observed name: G. Ferrara
ORCID: 0000-0003-0727-4015
Observed ORCID: 0000-0003-0727-4015
OpenAlex ID: A5058296489
Liquid biopsy in triple-negative breast cancer: a promising tool for diagnosis, prognosis, and treatment monitoring
2026 · Marianna Rita Brogna, Gerardo Ferrara, et al. · Frontiers in Oncology · 10
PDF
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study
2025 · Gian Franco Zannoni, Giuseppe Angelico, et al. · International Journal of Molecular Sciences · 8
PDF
The Impact of Next‐Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms
2025 · Julia Edwin Jeyakumar, Afua Konadu Addo, et al. · Journal of Cutaneous Pathology · 5
PDF
International Dermoscopy Society consensus recommendations for the management of lentigo maligna
2026 · Ana‐Maria Forsea, Riccardo Pampena, et al. · Journal of the European Academy of Dermatology and Venereology · 3
The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors
2026 · Jonathan Braat, Nithya Sai Trichy, et al. · Human Pathology · 2
Engineering the Image Representation for Deep Learning in Contrast-Enhanced Mammography: A Systematic Analysis of Preprocessing and Anatomical Masking
2026 · Roberta Fusco, Vincenza Granata, et al. · Bioengineering · 2
PDF
Bispecific Antibodies in Breast Cancer Immunotherapy: Mechanisms, Advances, and Translational Challenges
2026 · Marianna Rita Brogna, Gerardo Ferrara, et al. · Targeted Oncology · 2
PDF
Genomic profiling of a DICER1-wildtype thyroblastoma reveals AGK-BRAF fusion, EIF1AX duplication, and TERT promoter mutations: integrated genomic and pathway analysis
2026 · Alberto Gualandi, Fernanda Picozzi, et al. · Frontiers in Endocrinology · 1
Clinically Robust Deep Learning for Contrast-Enhanced Mammography: Multicenter Evaluation Across Convolutional Neural Network Architectures
2026 · Roberta Fusco, Vincenza Granata, et al. · Bioengineering · 1
PDF
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome during treatment with the bivalent CD20xCD3 bispecific antibody glofitamab
2026 · Alberto Fresa, Annarosa Cuccaro, et al. · Haematologica · 1
Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy
2026 · Vincenzo Ingangi, Roberta Gatti, et al. · Cells · 1
PDF
Domain-Adaptive Transfer Learning for HPV Lesion Classification in Whole Slide Images: A Patient-Level Pipeline Across the Cytology–Histology Continuum
2026 · Annabella Di Mauro, Pasquale De Luca, et al. · Bioengineering
Metastatic melanoma with heterologous bone after neoadjuvant immunotherapy: diagnostic insights
2026 · Ludovica Pepe, Vincenzo Fiorentino, et al. · Pathologica
PDF
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation‐Wide Study by the Italian Melanoma Intergroup ( IMI )
2026 · Bruna Dalmasso, Maria Chiara Scaini, et al. · Pigment Cell & Melanoma Research
Management of severe dysplastic nevus (high-grade dysplasia): Italian recommendations for good clinical practice
2026 · Cesare Massone, Giuseppe Argenziano, et al. · Dermatology Reports
Effect of MPATH‐Dx 2.0 on Diagnostic Agreement in the Histopathologic Assessment of Melanocytic Skin Lesions
2026 · Belinda Lai, Lin Zhu, et al. · JEADV Clinical Practice
Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project
2026 · Bruna Cerbelli, GIPaM working group, et al. · Pathologica
200P Immune checkpoint inhibition triggers systemic SDF-1 elevation, cardiac DAMPs release, and NLRP3–MyD88–chemokine activation: Mechanistic insights into immunotherapy-associated cardiotoxicity
2025 · V. Quagliariello, M. Passariello, et al. · Immuno-Oncology Technology
Effects of SGLT2i dapagliflozin in primary prevention of cardiotoxicity induced by short-term anthracycline and HER2 blocking agent therapy through inhibition of MyD88 and NLRP-3 pathways.
2025 · Vincenzo Quagliariello, Annabella Di Mauro, et al. · Journal of Clinical Oncology
PDF
AB059. The antero-superior mediastinum as unique metastatic site of primary unknown desmoplastic melanoma: a case report
2024 · Bianca Arianna Facchini, Erica Pietroluongo, et al. · Mediastinum
IL-6 could be a new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2022 · Domenico Mallardo, Ester Simeone, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 21
Citation count: 36
H-index: 3
I10-index: 1
Year
Topic
Type